Publications
5600 Results
- Journal / Conference
- Journal of Urology Vol. 199, No. 4S, Supplement, LBA26, p. e1166; American Urological Association Annual Meeting 2018
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8141
Phase II trial of neoadjuvant chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma (HG UTUC): results from ECOG-ACRIN 8141
- Journal / Conference
- JCO Clinical Cancer Informatics Dec;2:1-8; DOI: 10.1200/CCI.17.00122; online 2/2/18
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID30652537
- PMC
- PMC6668704
Incorporating digital tools to improve clinical trial infrastructure: A white paper from the digital engagement committee of SWOG [Special Article]
- Journal / Conference
- Blood 132:6; doi: https://doi.org/10.1182/blood-2018-99-116653; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral/plenary
- Year
- 2018
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/A041202
Ibrutinib alone or in combination with rituximab produces superior progression free survival compared with bendamustine plus rituximab in untreated older patients with chronic lymphocytic leukemia: Results of Alliance North American Intergroup Study A041202
- Journal / Conference
- European Urology Focus Jul;4(4):522-524
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID30197040
- Study Number(s)
- S1602
Background and update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer”
- Journal / Conference
- Lancet Haematology Dec;5(12):e609-e617
- Year
- 2018
- Research Committee(s)
- Lymphoma
- PMID
- PMID30501868
- PMC
- PMC6342507
- Study Number(s)
- CTSU/9177
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
- Journal / Conference
- Journal of Urology Vol. 199, No. 4S, Supplement, abst PD66-01; American Urological Association Annual Meeting (May 18-21, 2018, San Francisco, CA),
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0337
Immediate Post TURB Intravesical Gemcitabine: A cost comparison of SWOG S0337
- Journal / Conference
- American Society of Human Genetics (Oct 16-20, San Diego, CA), accepted, poster #2614T
- Year
- 2018
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000C
Replicated association of CYP4F2 variant with change in plasma vitamin E level after supplementation
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster
- Year
- 2018
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1202
Association between Body Mass Index (BMI) and Response to Duloxetine for Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms (AIMSS)
- Journal / Conference
- International Symposium on Hodgkin Lymphoma (October 27-29, 2018, Cologne, Germany), abst #T019 (0026), oral
- Year
- 2018
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Potential impact of consolidation radiation therapy for advanced Hodgkin Lymphoma: a secondary modeling analysis of SWOG S0816
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 4-8, 2018, San Antonio, TX), poster, P4-08-06
- Year
- 2018
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9313